Key result
The pathophysiological mechanisms of liver steatosis in NAFLD are multifactorial, involving insulin resistance, fatty acid retention, oxidative stress, and altered transcriptional factor expression.
This review summarizes the multifactorial molecular mechanisms underlying NAFLD, emphasizing the role of insulin resistance and lipid metabolism alterations.
This is the authors' abstract. We don't add key points for this paper.
Nonalcoholic fatty liver disease (NAFLD) is the most important cause of chronic liver disease and is considered the hepatic manifestation of the metabolic syndrome associated with diabetes mellitus type 2. The prevalence of NAFLD in the general population reaches 15-20%. It is also estimated that nonalcoholic steatohepatitis (NASH) affects 3% of the population. NAFLD refers to a wide spectrum of liver damage, which ranges from simple steatosis or intracellular triglyceride accumulation, to inflammation (NASH), fibrosis and cirrhosis. The mechanisms involved in the accumulation of triglycerides in the liver and subsequent hepatocellular damage are multifactorial and are not completely understood. However, metabolic changes such as insulin resistance (IR) are developed, being a common factor in the retention of fatty acids (FA) within the hepatocytes with oxidation and production of free radicals at the mitochondrial level, which are capable of causing lipid peroxidation, cytokine production, and necrosis. In addition, there are alterations in the hepatic bioavailability of long chain n-3 polyunsaturated fatty acids, conditions that alter the expression of a series of transcriptional factors involved in lipolytic and lipogenic processes in the liver. A greater knowledge of the etiopathogenic mechanisms of NAFLD is fundamental for the development of future effective therapeutic strategies. The pathophysiological fundamentals of liver steatosis are analyzed in this study.
Answers are grounded in this paper and cite their sources.
Multifactorial NAFLD mechanisms warrant holistic assessment; leaves open dominant pathway targeting for trials.
No takes yet. Share an insight, caveat, or question.
Pettinelli et al. (2012) conducted a review in Nonalcoholic fatty liver disease (NAFLD). The pathophysiological mechanisms of liver steatosis in NAFLD are multifactorial, involving insulin resistance, fatty acid retention, oxidative stress, and altered transcriptional factor expression.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: